About: http://data.cimple.eu/news-article/be034f04bc7482741f2da22934f122fd922a98b2c05a5a88856f4580

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/be034f04bc7482741f2da22934f122fd922a98b2c05a5a88856f4580 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	European Commission chief Ursula von der Leyen announced Friday that the AstraZeneca-Oxford University coronavirus vaccine has been authorised for the EU market, hours after the bloc's drug regulator recommended its approval. It is the third vaccine approved for use in the 27-nation EU, after rival shots produced by Pfizer-BioNTech and Moderna. "I expect the company to deliver the 400 million doses as agreed," von der Leyen tweeted, as a row intensified between Brussels and AstraZeneca. "We will keep on doing all we can to secure vaccines for Europeans, our neighbours & partners worldwide." The British-Swedish company has admitted it will only be able to deliver a fraction of the doses promised to the EU in the short-term due to production problems. That has come as a huge blow to Europe's already struggling rollout effort, while setting the EU on a collision course with former member Britain as they jostle for AstraZeneca's limited supplies. The approval of AstraZeneca's vaccine also comes in the middle of a controversy over the jab within the EU itself. Germany's vaccine commission said Thursday that the vaccine should not be used on over-65s due to insufficient evidence that it works. Even after the European Medicines Agency (EMA) recommended the AstraZeneca's shot be approved for all ages on Friday, the German panel maintained its stance. zap/jug/dl/har
schema:headline	EU authorises AstraZeneca vaccine: Commission chief
schema:mentions	Jug European Commission House of Leyen European Medicines Agency Brussels Jab Ursula von der Leyen AstraZeneca European Union Vaccine Severe acute respiratory syndrome coronavirus 2
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2021-01-29 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	neutral sentiment
http://data.cimple...readability_score	82 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 11 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software